← 產業報告目錄
Tumor Microenvironment Market Size, Share & Trends Analysis Report By Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Bladder Cancer and Others (Melanoma, Kidney cancer, Ovarian cancer etc.)), By Target, By Therapy, By End User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-10頁數 179報告編號 INSIGHTACE-d48f390a22
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Tumor Microenvironment Market worldwide was assessed at USD 1.7 Billion. Analysts project it will increase to USD 5.6 Billion by 2034, at a CAGR of 13.2% spanning 2025 to 2034.
At its core, Tumor Microenvironment pertains to The complex and dynamic environment around a tumour, which includes a range of cells, blood vessels, immune cells, signalling chemicals, and the extracellular matrix, is known as the tumour microenvir. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
The market's upward path is underpinned by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Tumor Microenvironment Market Snapshot
Chapter 4. Global Tumor Microenvironment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Cancer Type Estimates & Trend Analysis
5.1. By Cancer Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Cancer Type:
5.2.1. Lung Cancer
5.2.2. Colorectal Cancer
5.2.3. Breast Cancer
5.2.4. Prostate Cancer
5.2.5. Bladder Cancer
5.2.6. Others
Chapter 6. Market Segmentation 2: By Target Estimates & Trend Analysis
6.1. By Target & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Target:
6.2.1. T Cells
6.2.2. Tumor-Associated Macrophages
6.2.3. Myeloid-Derived Suppressor Cells
6.2.4. Cancer-Associated Fibroblasts
6.2.5. Regulatory T Cells
6.2.6. Others
Chapter 7. Market Segmentation 3: By Therapy Estimates & Trend Analysis
7.1. By Therapy & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapy:
7.2.1. Monoclonal Antibodies
7.2.2. Cytokines
7.2.3. Cancer Vaccines
7.2.4. Oncolytic Viruses
7.2.5. Adoptive Cell Therapies
7.2.6. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Biopharmaceutical Companies
8.2.2. Hospitals
8.2.3. Diagnostic Laboratories
8.2.4. Research Institutes
8.2.5. Contract Research Organizations (CROs)
8.2.6. Others
Chapter 9. Tumor Microenvironment Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Tumor Microenvironment Market revenue (US$ Million) estimates and forecasts By Cancer Type, 2021-2034
9.1.2. North America Tumor Microenvironment Market revenue (US$ Million) estimates and forecasts By Target, 2021-2034
9.1.3. North America Tumor Microenvironment Market revenue (US$ Million) estimates and forecasts By Therapy, 2021-2034
9.1.4. North America Tumor Microenvironment Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.1.5. North America Tumor Microenvironment Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Tumor Microenvironment Market revenue (US$ Million) By Cancer Type, 2021-2034
9.2.2. Europe Tumor Microenvironment Market revenue (US$ Million) By Target, 2021-2034
9.2.3. Europe Tumor Microenvironment Market revenue (US$ Million) By Therapy, 2021-2034
9.2.4. Europe Tumor Microenvironment Market revenue (US$ Million) By End User, 2021-2034
9.2.5. Europe Tumor Microenvironment Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Tumor Microenvironment Market revenue (US$ Million) By Cancer Type, 2021-2034
9.3.2. Asia Pacific Tumor Microenvironment Market revenue (US$ Million) By Target, 2021-2034
9.3.3. Asia Pacific Tumor Microenvironment Market revenue (US$ Million) By Therapy, 2021-2034
9.3.4. Asia Pacific Tumor Microenvironment Market revenue (US$ Million) By End User, 2021-2034
9.3.5. Asia Pacific Tumor Microenvironment Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Tumor Microenvironment Market revenue (US$ Million) By Cancer Type, (US$ Million) 2021-2034
9.4.2. Latin America Tumor Microenvironment Market revenue (US$ Million) By Target, (US$ Million) 2021-2034
9.4.3. Latin America Tumor Microenvironment Market revenue (US$ Million) By Therapy, (US$ Million) 2021-2034
9.4.4. Latin America Tumor Microenvironment Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
9.4.5. Latin America Tumor Microenvironment Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Tumor Microenvironment Market revenue (US$ Million) By Cancer Type, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Tumor Microenvironment Market revenue (US$ Million) By Target, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Tumor Microenvironment Market revenue (US$ Million) By Therapy, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Tumor Microenvironment Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
9.5.5. Middle East & Africa Tumor Microenvironment Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific,
10.2.2. Illumina,
10.2.3. Danaher Corporation,
10.2.4. Merck KGaA,
10.2.5. BD Biosciences,
10.2.6. Promega Corporation,
10.2.7. Bio-Techne Corporation,
10.2.8. Bio-Rad Laboratories,
10.2.9. F. Hoffmann-La Roche Ltd,
10.2.10. QIAGEN N.V.,
10.2.11. Sartorius AG,
10.2.12. PerkinElmer,
10.2.13. Miltenyi Biotec,
10.2.14. Cell Signaling Technology,
10.2.15. BioLegend,
10.2.16. Abcam,
10.2.17. Takara Bio,
10.2.18. Fluidigm Corporation,
10.2.19. NanoString Technologies,
10.2.20. 10x Genomics,
10.2.21. Bethyl Laboratories
10.2.22. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們